Cargando…

A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's disease

Background: Delayed gastric emptying may impair l‐dopa absorption, contributing to motor fluctuations. We evaluated the effect of camicinal (GSK962040), a gastroprokinetic, on the absorption of l‐dopa and symptoms of PD. Methods: Phase II, double‐blind, placebo‐controlled trial. Participants were ra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marrinan, Sarah L., Otiker, Tal, Vasist, Lakshmi S., Gibson, Rachel A., Sarai, Bhopinder K., Barton, Matthew E., Richards, Duncan B., Hellström, Per M., Nyholm, Dag, Dukes, George E., Burn, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Brief Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5838770/ https://www.ncbi.nlm.nih.gov/pubmed/29278279 http://dx.doi.org/10.1002/mds.27259

Ejemplares similares

The effect of camicinal (GSK962040), a motilin agonist, on gastric emptying and glucose absorption in feed-intolerant critically ill patients: a randomized, blinded, placebo-controlled, clinical trial
por: Chapman, Marianne J., et al.
Publicado: (2016)

Effects of Helicobacter pylori on Levodopa Pharmacokinetics
por: Nyholm, Dag, et al.
Publicado: (2021)

The effects of alcohol on the pharmacokinetics and pharmacodynamics of the selective mu-opioid receptor antagonist GSK1521498 in healthy subjects
por: Ziauddeen, Hisham, et al.
Publicado: (2013)

Opioid Antagonists and the A118G Polymorphism in the μ-Opioid Receptor Gene: Effects of GSK1521498 and Naltrexone in Healthy Drinkers Stratified by OPRM1 Genotype
por: Ziauddeen, Hisham, et al.
Publicado: (2016)

Gastric emptying assessment in critically ill patients with feed intolerance; comparison of (13)C octanoic acid, paracetamol and 3-O-methylglucose absorption tests
por: Chapman, M, et al.
Publicado: (2012)

Optimizing Treatment of Parkinson’s Disease
por: Nyholm, Dag, et al.
Publicado: (2022)

Close relationships in Parkinson´s disease patients with device‐aided therapy
por: Scharfenort, Monica, et al.
Publicado: (2021)

Fermentable oligo-, di-, monosaccharides, and polyols (FODMAPs), but not gluten, elicit modest symptoms of irritable bowel syndrome: a double-blind, placebo-controlled, randomized three-way crossover trial
por: Nordin, Elise, et al.
Publicado: (2021)

Development of new levodopa treatment strategies in Parkinson’s disease—from bedside to bench to bedside
por: Aquilonius, Sten-Magnus, et al.
Publicado: (2017)

Levodopa–entacapone–carbidopa intestinal gel infusion in advanced Parkinson’s disease: real-world experience and practical guidance
por: Nyholm, Dag, et al.
Publicado: (2022)

Levodopa/carbidopa microtablets in Parkinson’s disease: a study of pharmacokinetics and blinded motor assessment
por: Senek, Marina, et al.
Publicado: (2017)

Population pharmacokinetics of levodopa/carbidopa microtablets in healthy subjects and Parkinson’s disease patients
por: Senek, Marina, et al.
Publicado: (2018)

Safety and tolerability of IRL790 in Parkinson’s disease with levodopa-induced dyskinesia—a phase 1b trial
por: Svenningsson, Per, et al.
Publicado: (2018)

Automatic and Objective Assessment of Alternating Tapping Performance in Parkinson's Disease
por: Memedi, Mevludin, et al.
Publicado: (2013)

Personalized Medicine Approach in Treating Parkinson’s Disease, Using Oral Administration of Levodopa/Carbidopa Microtablets in Clinical Practice
por: Grétarsdóttir, Helga María, et al.
Publicado: (2021)

Verification of a Method for Measuring Parkinson’s Disease Related Temporal Irregularity in Spiral Drawings
por: Aghanavesi, Somayeh, et al.
Publicado: (2017)

Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease
por: Bergquist, Filip, et al.
Publicado: (2022)

Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study
por: Polymeropoulos, Vasilios M., et al.
Publicado: (2020)

Toward Improved Treatment and Empowerment of Individuals With Parkinson Disease: Design and Evaluation of an Internet of Things System
por: Karni, Liran, et al.
Publicado: (2022)

A survey of lifestyle factors in dystonia
por: Söderlund, Jacob, et al.
Publicado: (2020)

Evaluation of cariprazine in the treatment of bipolar I and II depression: a randomized, double-blind, placebo-controlled, phase 2 trial
por: Yatham, Lakshmi N., et al.
Publicado: (2020)

Imaging features associated with idiopathic normal pressure hydrocephalus have high specificity even when comparing with vascular dementia and atypical parkinsonism
por: Fällmar, David, et al.
Publicado: (2021)

Creatine supplementation and physical training in patients with COPD: A double blind, placebo-controlled study
por: Faager, Gun, et al.
Publicado: (2006)

The effects of Bacillus coagulans MTCC 5856 on functional gas and bloating in adults: A randomized, double-blind, placebo-controlled study
por: Majeed, Muhammed, et al.
Publicado: (2023)

Coenzyme Q10 in the Treatment of Heart Failure with Preserved Ejection Fraction: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
por: Samuel, Tal Y., et al.
Publicado: (2021)

Managing the painful blind eye
por: Penniecook, Jason A, et al.
Publicado: (2021)

The Polarizing Impact of Political Disinformation and Hate Speech: A Cross-country Configural Narrative
por: Vasist, Pramukh Nanjundaswamy, et al.
Publicado: (2023)

A double-blind placebo needle for acupuncture research
por: Takakura, Nobuari, et al.
Publicado: (2007)

Memantine for axial signs in Parkinson's disease: a randomised, double-blind, placebo-controlled pilot study
por: Moreau, Caroline, et al.
Publicado: (2013)

Zishenpingchan granules for the treatment of Parkinson’s disease: a randomized, double-blind, placebo-controlled clinical trial
por: Ye, Qing, et al.
Publicado: (2018)

Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study
por: Choi, Ji‐Hyun, et al.
Publicado: (2020)

Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
por: Yoritaka, Asako, et al.
Publicado: (2021)

Sensor-based algorithmic dosing suggestions for oral administration of levodopa/carbidopa microtablets for Parkinson’s disease: a first experience
por: Thomas, Ilias, et al.
Publicado: (2019)

Do randomized clinical trials with inadequate blinding report enhanced placebo effects for intervention groups and nocebo effects for placebo groups?
por: Feys, Frederik, et al.
Publicado: (2014)

Stratification, Blinding and Placebo Effect in a Randomized, Double Blind Placebo-controlled Clinical Trial of Gold Bead Implantation in Dogs with Hip Dysplasia
por: Jæger, GT, et al.
Publicado: (2005)

The Effect of Azithromycin in Adults with Stable Neutrophilic COPD: A Double Blind Randomised, Placebo Controlled Trial
por: Simpson, Jodie L., et al.
Publicado: (2014)

Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects
por: Becker, Anna M., et al.
Publicado: (2021)

A randomised, double-blind, placebo controlled cross-over study to determine the gastrointestinal effects of consumption of arabinoxylan-oligosaccharides enriched bread in healthy volunteers
por: Walton, Gemma E, et al.
Publicado: (2012)

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM)
por: Erdal, Ane, et al.
Publicado: (2018)

A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of a Nutritional Supplement (ImmuActive(TM)) for COVID-19 Patients
por: Majeed, Muhammed, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t5j1pahhvnvf78d5l98bm27973